1.武汉大学人民医院重症医学科 湖北 武汉 430060
2.麻城市中医医院重症医学科 湖北 麻城 438300
3.复旦大学附属中山医院急诊科/复旦大学应急救援与急危重症研究所 上海 200032
4.浙江大学医学院附属第二医院重症医学科/浙江省急危重症临床医学研究中心 浙江 杭州 310009
5.南方医科大学附属广东省人民医院/广东省医学科学院重症医学科 广东 广州 510000
王璐,女,1987—,医学博士,主要从事ARDS临床及机制研究,E‑mail: wanglu@whu.edu.cn
詹丽英,女,1971—,医学博士,主任医师,主要从事ARDS临床及机制研究,E‑mail: zhanliying@whu.edu.cn
收稿:2024-07-02,
纸质出版:2025-02-25
移动端阅览
王璐,左小淑,高文蔚等.一氧化氮吸入治疗急性呼吸窘迫综合征的临床疗效[J].武汉大学学报(医学版),2025,46(02):187-193.
WANG Lu,ZUO Xiaoshu,GAO Wenwei,et al.Clinical efficacy of inhaled nitric oxide therapy for acute respiratory distress syndrome[J].Medical Journal of Wuhan University,2025,46(02):187-193.
王璐,左小淑,高文蔚等.一氧化氮吸入治疗急性呼吸窘迫综合征的临床疗效[J].武汉大学学报(医学版),2025,46(02):187-193. DOI: 10.14188/j.1671-8852.2024.0490.
WANG Lu,ZUO Xiaoshu,GAO Wenwei,et al.Clinical efficacy of inhaled nitric oxide therapy for acute respiratory distress syndrome[J].Medical Journal of Wuhan University,2025,46(02):187-193. DOI: 10.14188/j.1671-8852.2024.0490.
目的
2
评估一氧化氮吸入(iNO)联合标准治疗对急性呼吸窘迫综合征(ARDS)患者的影响。
方法
2
采集2019年1月—2024年4月的ARDS患者共406例,按照1∶1倾向性评分匹配(PSM)后,分为iNO联合标准治疗(I+S)组和标准治疗(S)组,每组各35例,评估治疗后患者的平均肺动脉压、动脉氧分压/吸入氧浓度百分比(PaO
2
/FiO
2
)、28 d死亡率等指标。
结果
2
在治疗24 h和48 h后,I+S组患者的平均肺动脉压显著低于S组(
P
<
0.05)。而且,I+S组的PaO
2
/FiO
2
在治疗后显著上升(
P
<
0.05)、可溶性生长刺激表达基因蛋白2(sST2)水平显著下降(
P
<
0.05)。比较两组非机械通气时间、ICU住院时间、持续性肾脏替代治疗(CRRT)和体外膜肺氧合(ECMO)使用率、28 d死亡率,差异无统计学意义(
P
>
0.05)。
结论
2
一氧化氮吸入联合标准治疗在改善ARDS患者的肺动脉压、氧合和心肌标志物方面显示出潜在的益处。
Objective
2
To evaluate the effect of nitric oxide inhalation (iNO) combined with standard therapy on patients with acute respiratory distress syndrome (ARDS).
Methods
2
A total of 406 ARDS patients collected from January 2019 to April 2024 were divided into two groups: the iNO combined with standard treatment (I+S) group and the standard treatment (S) group
with 35 patients in each group
according to a 1∶1 propensity score matching (PSM). The mean pulmonary artery pressure
arterial oxygen pressure/inspiratory oxygen fraction ratio (PaO
2
/FiO
2
)
28‑day mortality
and other treatment outcomes were evaluated.
Results
2
After 24 and 48 hours of treatment
respectively
the mean pulmonary artery pressure in the I+S group was significantly lower than in the S group (
P
<
0.05). In addition
PaO
2
/FiO
2
in the I+S group was significantly increased after treatment (
P
<
0.05)
and the sST2 level was significantly decreased (
P
<
0.05). No significant difference was found in the duration of non⁃mechanical ventilation
length of ICU stay
use of continuous renal replacement therapy (CRRT) and extracorporeal membrane oxygenation (E
CMO)
and 28⁃day mortality between the two groups (
P
<
0.05).
Conclusion
2
iNO combined with standard therapy shows potential benefits in improving pulmonary artery pressure
oxygenation
and cardiac biomarkers in patients with ARDS.
Gorman E A , O'Kane C M , McAuley D F . Acute respiratory distress syndrome in adults: Diagnosis, outcomes, long‑term sequelae, and management [J ] . Lancet , 2022 , 400 ( 10358 ): 1157 ‑ 1170 .
Bellani G , Laffey J G , Pham T , et al . Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries [J ] . JAMA , 2016 , 315 ( 8 ): 788 ‑ 800 .
Zafar K . Incidence of acute respiratory distress syndrome [J ] . JAMA , 2016 , 316 ( 3 ): 347 .
Grasselli G , Calfee C S , Camporota L , et al . ESICM guidelines on acute respiratory distress syndrome: Definition, phenotyping and respiratory support strategies [J ] . Intensive Care Med , 2023 , 49 ( 7 ): 727 ‑ 759 .
Borek I , Birnhuber A , Voelkel N F , et al . The vascular perspective on acute and chronic lung disease [J ] . J Clin Invest , 2023 , 133 ( 16 ): e170502 .
Revercomb L , Hanmandlu A , Wareing N , et al . Mechanisms of pulmonary hypertension in acute respiratory distress syndrome (ARDS) [J ] . Front Mol Biosci , 2020 , 7 : 624093 .
Lazzeri C , Cianchi G , Bonizzoli M , et al . Right ventricle dilation as a prognostic factor in refractory acute respiratory distress syndrome requiring veno‑venous extracorporeal membrane oxygenation [J ] . Minerva Anestesiol , 2016 , 82 ( 10 ): 1043 ‑ 1049 .
Strickland B , Stuart Harris N . Adapting nitric oxide: A review of its foundation, uses in austere medical conditions, and emerging applications [J ] . Nitric Oxide , 2024 , 146 : 58 ‑ 63 .
Bosch N A , Law A C , Vail E A , et al . Inhaled nitric oxide vs epoprostenol during acute respiratory failure: An observational target trial emulation [J ] . Chest , 2022 , 162 ( 6 ): 1287 ‑ 1296 .
Redaelli S , Pozzi M , Giani M , et al . Inhaled nitric oxide in acute respiratory distress syndrome subsets: Rationale and clinical applications [J ] . J Aerosol Med Pulm Drug Deliv , 2023 , 36 ( 3 ): 112 ‑ 126 .
Gebistorf F , Karam O , Wetterslev J , et al . Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults [J ] . Cochrane Database Syst Rev , 2016 , 2016 ( 6 ): CD002787 .
Ruan S Y , Huang T M , Wu H Y , et al . Inhaled nitric oxide therapy and risk of renal dysfunction: A systematic review and meta‑analysis of randomized trials [J ] . Crit Care , 2015 , 19 ( 1 ): 137 .
ARDS Definition Task Force , Ranieri V M , Rubenfeld G D , et al . Acute respiratory distress syndrome: The Berlin Definition [J ] . JAMA , 2012 , 307 ( 23 ): 2526 ‑ 2533 .
Saydain G , Awan A , Manickam P , et al . Pulmonary hypertension an independent risk factor for death in intensive care unit: Correlation of hemodynamic factors with mortality [J ] . Clin Med Insights Circ Respir Pulm Med , 2015 , 9 : 27 ‑ 33 .
Sato R , Dugar S , Cheungpasitporn W , et al . The impact of right ventricular injury on the mortality in patients with acute respiratory distress syndrome: A systematic review and meta‑analysis [J ] . Crit Care , 2021 , 25 ( 1 ): 172 .
Mekontso Dessap A , Boissier F , Charron C , et al . Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: Prevalence, predictors, and clinical impact [J ] . Intensive Care Med , 2016 , 42 ( 5 ): 862 ‑ 870 .
Sud S , Fan E , Adhikari N K J , et al . Comparison of venovenous extracorporeal membrane oxygenation, prone position and supine mechanical ventilation for severely hypoxemic acute respiratory distress syndrome: A network meta‑analysis [J ] . Intensive Care Med , 2024 , 50 ( 7 ): 1021 ‑ 1034 .
Lecompte‑Osorio P , Pearson S D , Pieroni C H , et al . Bedside estimates of dead space using end‑tidal CO 2 are independently associated with mortality in ARDS [J ] . Crit Care , 2021 , 25 ( 1 ): 333 .
Fierobe L , Brunet F , Dhainaut J F , et al . Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome [J ] . Am J Respir Crit Care Med , 1995 , 151 ( 5 ): 1414 ‑ 1419 .
Rossaint R , Slama K , Steudel W , et al . Effects of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome [J ] . Intensive Care Med , 1995 , 21 ( 3 ): 197 ‑ 203 .
Taylor R W , Zimmerman J L , Dellinger R P , et al . Low‑dose inhaled nitric oxide in patients with acute lung injury: A randomized controlled trial [J ] . JAMA , 2004 , 291 ( 13 ): 1603 ‑ 1609 .
蒋志彬 , 刘励军 , 王英 , 等 . 一氧化氮吸入对感染性休克并发急性呼吸窘迫综合征患者氧合功能的作用及血流动力学的安全性研究 [J ] . 中国危重病急救医学 , 2000 , 12 ( 9 ): 549 ‑ 551 .
Jiang Z B , Liu L J , Wang Y , et al . Study on the effects of nitric oxide inhalation on the improvement of oxygenation and hemodynamic status in patients with septic shock complicated with acute respiratory distress syndrome [J ] . Chin Crit Care Med , 2000 , 12 ( 9 ): 549 ‑ 551 .
赵鸣雁 , 马勇胜 , 于凯江 , 等 . 外源性一氧化氮吸入治疗急性呼吸窘迫综合征 [J ] . 中国急救医学 , 2002 , 22 ( 8 ): 454 ‑ 455 .
Zhao M Y , Ma Y S , Yu K J , et al . Inhaled extrinsic nitric oxide to treat ARDS [J ] . Chin J Crit Care Med , 2002 , 22 ( 8 ): 454 ‑ 455 .
杜亚芳 , 黄国华 , 徐小彭 , 等 . 两种同期联合吸入一氧化氮治疗重度急性呼吸窘迫综合征致难治性呼吸衰竭的临床疗效对比分析 [J ] . 中华肺部疾病杂志 (电子版), 2018 , 11 ( 1 ): 82 ‑ 85 .
Du Y F , Huang G H , Xu X P , et al . Comparison of two kinds of simultaneous inhalation of nitric oxide in the treatment of severe acute respiratory distress syndrome with refractory respiratory failure [J ] . Chin J Lung Dis Electron Ed , 2018 , 11 ( 1 ): 82 ‑ 85 .
Adhikari N K , Dellinger R P , Lundin S , et al . Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: Systematic review and meta‑analysis [J ] . Crit Care Med , 2014 , 42 ( 2 ): 404 ‑ 412 .
中国研究型医院学会危重医学专委会 , 宁波诺丁汉大学GRADE中心 . 中国成人急性呼吸窘迫综合征(ARDS)诊断与非机械通气治疗指南(2023) [J ] . 中国研究型医院 , 2023 , 10 ( 5 ): 9 ‑ 24 .
Chinese Society of Critical Care Medicine , Research Hospital Association , Ningbo Nottingham University GRADE Center . Guidelines for diagnosis of adult acute respiratory distress syndrome(ARDS) in China and non‑mechanical ventilation treatment(2023) [J ] . J Chin Res Hosp , 2023 , 10 ( 5 ): 9 ‑ 24 .
Bonizzoli M , Lazzeri C , Cianchi G , et al . Effects of rescue inhaled nitric oxide on right ventricle and pulmonary circulation in severe COVID‑related acute respiratory distress syndrome [J ] . J Crit Care , 2022 , 72 : 153987 .
Al Sulaiman K , Korayem G B , Altebainawi A F , et al . Evaluation of inhaled nitric oxide (iNO) treatment for moderate‑to‑severe ARDS in critically ill patients with COVID‑19: A multicenter cohort study [J ] . Crit Care , 2022 , 26 ( 1 ): 304 .
Yao X I , Wang X F , Speicher P J , et al . Reporting and guidelines in propensity score analysis: A systematic review of cancer and cancer surgical studies [J ] . J Natl Cancer Inst , 2017 , 109 ( 8 ): djw323 .
Matthay M A , Arabi Y , Arroliga A C , et al . A new global definition of acute respiratory distress syndrome [J ] . Am J Respir Crit Care Med , 2024 , 209 ( 1 ): 37 ‑ 47 .
0
浏览量
15
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621